Application 211532
- Type
- ANDA
- Sponsor
- LUPIN LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATE | DAPAGLIFLOZIN, SAXAGLIPTIN MONOHYDRATE | TABLET; ORAL | 5MG | No | No |
| 002 | DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATE | DAPAGLIFLOZIN, SAXAGLIPTIN MONOHYDRATE | TABLET; ORAL | 10MG | No | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.